NEW YORK (GenomeWeb News) – Two new Australian cancer-focused genomics research centers are scheduled for their official launch tomorrow in Queensland, according to the Australia Cancer Research Foundation (ACRF).
The ACRF Centre for Cancer Epigenetics at the Queensland Institute of Medical Research and the ACRF Comprehensive Cancer Genomics Centre at the University of Queensland Diamantina Institute (UQDI) were developed with A$5.9 million (US$6.2 million) in ACRF seed funding.
Researchers at the Centre for Cancer Epigenetics will seek to identify genes involved in cancer and study the relationships between genetics, cancer, and environmental factors.
Scientists at The Comprehensive Cancer Genomics Centre also will study the causes of cancer and zero in on how inherited risk factors and genetic mutations cause cancer.
"Epigenetics is an exciting, emerging field and the ultimate aim of the Centre is to aid in providing information that may help in the development of therapies to maintain the health of genes and thus act as a preventative measure for cancer," QIMR Professor Emma Whitelaw said in a statement.
"The ACRF Comprehensive Cancer Genomics Facility will provide researchers with unprecedented abilities to study the basic genetic causes of cancer, work out how those genetic factors cause disease, and importantly then to translate that back to the clinic by identifying potential cancer treatments," said UQDI Director Matt Brown.